Skip to search formSkip to main contentSkip to account menu

AD 4833

Known as: AD-4833 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

pioglitazone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
[Discovery and development of a new insulin sensitizing agent, pioglitazone].
Insulin resistance is a characteristic feature of type II diabetes as well as obesity. This insulin resistant state at the… 
1997
1997
Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.
Metabolic studies of pioglitazone (CAS 105355-27-9, AD-4833), a new agent, in rats and dogs using liquid chromatography/tandem… 
Review
1997
Review
1997
[Clinical efficacy of Pioglitazone (AD-4833)].
Review
1997
Review
1997
[Preclinical studies of pioglitazone (AD-4833)].
1993
1993
Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
To investigate whether thiazolidinediones (AD-4833 and CS-045), new oral antidiabetic agents, are effective in insulin-dependent… 
Highly Cited
1992
Highly Cited
1992
Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
In the course of further chemical modification of the novel antidiabetic pioglitazone (AD-4833, U-72,107), a series of 5-[4-(2… 
1989
1989
Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatography with ultraviolet (229 nm) detection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)